A phase Ib dose-escalation study of the oral pan-PI3K inhibitor buparlisib (BKM120) in combination with the oral MEK1/2 inhibitor trametinib (GSK1120212) in patients with selected advanced solid tumors
| Image |  |
|---|---|
| Description | scientific article published on 10 December 2014 |
| Author/s |
author: Philippe L. Bedard Josep Tabernero Caturla Filip Janku |
| Publication date | December 10, 2014 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |